The Series A round, which included participation from North Island Ventures and existing investors, brings New York-based Mural's total funding to $28 million.
OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind. The goal is to build AI agents that help pharma teams coordinate drug development, from tracking trials to spotting problems. Developing a new drug in the US takes ten to 15 years on average. OpenAI already works with Novo Nordisk and Moderna on AI-driven pharma research.
Enterprises are deploying AI agents on top of incomplete and siloed workforce data that sit scattered across HR and finance systems and a decade of point solutions, each with its own definitions and blind spots.
Some of the most interesting moments in music production come when an arrangement won’t work. The groove is there and the melody is promising, but something
Google is integrating AI-related changes into its software engineer hiring process, according to internal documents. These updates include evaluating candidates for AI fluency and allowing AI use in coding interviews. Interviewers can also use Gemini for feedback.
Aesthetic code generation with decoupled cross-modal rewards: turning prompts into editable, verifiable HTML/CSS infographics, with image generators as aesthetic guidance.